Plus Therapeutics
Price & Volume
Stats
See more52W Range | $1.12-$2.67 |
Market Cap | $6.9M |
Shares Short | 52,339 |
Financials
See moreRevenue (12 Mos) | $5.5M |
Revenue Growth (YoY) | -31% |
Gross Profit (12 Mos) | -$9.4M |
Diluted EPS | -$2.37 |
News
See moreYahoo Finance • last year
Plus Therapeutics Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader Webinar
Yahoo Finance • last year
Plus Therapeutics to Host Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference on Monday, November 20, 2023
About
CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
CFO | Mr. Andrew J. Sims CPA |
Address | 4200 Marathon Boulevard, Austin, TX, United States, 78756 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
